The forecast indicates a continuous growth in the number of top-cited scientific publications in Pulmonary and Respiratory Medicine in China, with expectations moving from 131.6 publications in 2024 to 176.84 in 2028. In 2023, this number stood at a lower level reflective of actual data not disclosed here, marking a positive trajectory in scientific publication prominence over time. Year-on-year variations showcase steady growth, while the CAGR over the period from 2024 to 2028 highlights the sector's strengthening visibility and influence in scientific research.

For future trends, watch for:

Increasing investment in scientific research and innovation.
Enhanced international collaborations boosting citation impacts.
Potential impacts of policy changes in research funding and academic publishing.